Contineum Therapeutics Inc. Class A (CTNM) Live Share Price, Invest From India

Contineum Therapeutics Inc. Class A Stock Performance

as on July 20, 2026 at 2:15 pm IST

Day's Low
Day's High
$13.38
Day's Price Range
$14.52
$14.23
5.97%
Downside
2.04%
Upside
52 Week's Low
52 Week's High
$4.67
52-Week Price Range
$16.91
$14.23
67.18%
Downside
18.83%
Upside

Contineum Therapeutics Inc. Class A share price movements today

Previous Close: $14.01
Open: $13.74
Volume: 212.0K
Day's Low - High: $13.38 - $14.52
52 Week Low - High: $4.67 - $16.91

Contineum Therapeutics Inc. Class A Historical Returns

1 Month Return: + 19.18 %
3 Month Return: + 5.64 %
1 Year Return: + 227.13 %
3 Year Return: 0 %
5 Year Return: 0 %

Contineum Therapeutics Inc. Class A Stock Fundamentals & Key Indicators

Check Contineum Therapeutics Inc. Class A market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$532.0M

EPS (TTM)

-1.6471

Dividend Yield

0.00%

PE Ratio (TTM)

PEG Ratio

Return On Equity TTM

-26.88%

Contineum Therapeutics Inc. Class A vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Contineum Therapeutics Inc. Class A with its industry peers.

Company	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin %	Dividend Yield %
Contineum Therapeutics Inc. Class A	NA	$532.0M	NA	NA	0.00%	NA
Revolution Medicines Inc.	BUY	$39.6B	515.2%	NA	0.00%	NA
Vertex Pharmaceuticals Inc.	BUY	$123.3B	147.09%	28.82	35.51%	NA
Regeneron Pharmaceuticals Inc.	BUY	$70.9B	15.23%	16.53	29.65%	0.53%

Stock Returns calculator for Contineum Therapeutics Inc. Class A Stock including INR - Dollar returns

The Contineum Therapeutics Inc. Class A stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

Contineum Therapeutics Inc. Class A investment value today

Current value as on today

₹3,65,401

Returns

₹2,65,401

(+265.4%)

Returns from Contineum Therapeutics Inc. Class A Stock

₹2,27,126 (+227.13%)

Dollar Impact

₹38,274 (+38.27%)

Indian Investors' Interest in Contineum Therapeutics Inc. Class A Stock

Search interest for Contineum Therapeutics Inc. Class A Stock has increased by 329% in the last 30 days, reflecting an upward trend in search activity.

Time period: June 20, 2026 to July 20, 2026

Change:329% versus previous 30 day period

Contineum Therapeutics Inc. Class A Quarterly Profit & Loss

All numbers in Millions USD

	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026
Total Revenue	-	-	-	-	0	-	-	-	-	-
Gross Profit	0	0	0	-	0	-	0	0	0	0
Operating Income	-9	-9	-10	-12	84	-18	-17	-14	-17	-16
EBITDA	-7	-8	-8	-10	-14	-15	-15	-12	-15	-14
Interest Expense	-	-	-	-	-	-	-	-	-	-
Depreciation	0	0	0	0	0	0	0	0	0	0
Income Before Tax	-7	-8	-9	-10	-14	-15	-16	-12	-15	-14
Income Tax Expense	0	-	-	-	-	-	-	-	-	-
Net Income	-7	-8	-9	-10	-14	-15	-16	-12	-15	-14
Net Profit Margin	0.00%	0.00%	0.00%	0.00%	-6018.60%	0.00%	0.00%	0.00%	0.00%	0.00%

Contineum Therapeutics Inc. Class A Annual Profit & Loss

All numbers in Millions USD

	Dec 2021	Dec 2022	Dec 2023	Dec 2024	Dec 2025
Total Revenue	-	-	50	-	-
Gross Profit	-	0	50	0	0
Operating Income	-28	-22	-16	-50	-68
EBITDA	-28	-23	23	-42	-59
Interest Expense	0	0	0	-	-
Depreciation	0	0	0	0	0
Income Before Tax	-29	-24	23	-42	-59
Income Tax Expense	0	-	0	-	-
Net Income	-29	-24	22	-42	-59
Net Profit Margin	0.00%	0.00%	45.44%	0.00%	0.00%

Contineum Therapeutics Inc. Class A Quarterly Cash Flow

All numbers in Millions USD

	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026
Net Income	-8	-9	-10	-14	-15	-16	-12	-15	-14
Operating Cash Flow	-8	-8	-6	-10	-14	-15	-12	-13	-16
Investing Cash Flow	8	-38	-30	-9	14	13	14	-47	-39
Financing Cash Flow	0	108	0	0	0	0	19	93	0
Change in Cash	0	60	-36	-18	0	-1	21	32	-55

Contineum Therapeutics Inc. Class A Annual Cash Flow

All numbers in Millions USD

	Dec 2022	Dec 2023	Dec 2024	Dec 2025
Net Income	-24	22	-42	-59
Operating Cash Flow	-20	19	-32	-55
Investing Cash Flow	22	-65	-69	-3
Financing Cash Flow	-1	56	109	112
Change in Cash	0	9	6	53

Global Institutional Holdings in Contineum Therapeutics Inc. Class A

Funds	Holdings
FMR Inc	2.18%
Hillhouse Capital Advisors, Ltd.	1.79%
Sectoral Asset Management Inc	1.95%
Versant Venture Management LLC	1.45%
RA Capital Management, LLC	3.47%

See all

Insights on Contineum Therapeutics Inc. Class A

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

POSITIVE IMPACT
Price Rise
In the last 1 month, CTNM stock has moved up by 19.2%
NO EFFECT
Against Peers
In the last 1 year, Revolution Medicines, Inc. Common Stock has given 386.1% return, outperforming this stock by 159.0%

About Contineum Therapeutics Inc. Class A

Contineum Therapeutics, Inc., a clinical stage biopharmaceutical company, engages in developing of small molecules different therapies for neuroscience, inflammation, and immunology indications in the United States. The company's lead asset is PIPE-791, a novel, brain penetrant, small molecule inhibitor of the lysophosphatidic acid 1 receptor (LPA1R) for the treatment of idiopathic pulmonary fibrosis and chronic pain. It also develops PIPE-307, a novel, small-molecule inhibitor of the muscarinic type 1 receptor for depression and relapse-remitting multiple sclerosis. The company was formerly known as Pipeline Therapeutics, Inc. and changed its name to Contineum Therapeutics, Inc. in November 2023. Contineum Therapeutics, Inc. was incorporated in 2009 and is based in San Diego, California.

Organisation	Contineum Therapeutics Inc. Class A
Headquarters	3565 General Atomics Court, San Diego, CA, United States, 92121
Industry	Biotechnology
CEO	Mr. Carmine N. Stengone MBA, MS
E-voting on shares	Click here to vote

Key Management of Contineum Therapeutics Inc. Class A

Name	Title
Mr. Peter T. Slover CPA	Chief Financial Officer
Dr. Timothy R. Watkins M.D., M.Sc.	Chief Medical Officer & Head of Development
Ms. Morgan Paulsen	Senior Manager of Accounting
Dr. Daniel S. Lorrain Ph.D.	Chief Science Officer
Mr. Steve E. Kunszabo	Senior Director of Investor Relations & Corporate Communications
Mr. John S. Healy	General Counsel & Corporate Secretary
Mr. Carmine N. Stengone MBA, MS	President, CEO & Director

FAQs

What is Contineum Therapeutics Inc. Class A share price today?

Contineum Therapeutics Inc. Class A share price today is $14.23 as on July 20, 2026 at 8:45 am IST at the close of the market. Contineum Therapeutics Inc. Class A share today touched a day high of $14.52 and a low of $13.38.

What is the 52 week high and 52 week low for Contineum Therapeutics Inc. Class A share?

Contineum Therapeutics Inc. Class A share touched a 52 week high of $16.91 on June 30, 2026 and a 52 week low of $4.67 on July 21, 2025. Contineum Therapeutics Inc. Class A stock price today i.e. July 20, 2026 at 8:45 am IST is closed at $14.23,which is 15.85% down from its 52 week high and 204.71% up from its 52 week low.

What is Contineum Therapeutics Inc. Class A's market capitalisation today?

Contineum Therapeutics Inc. Class A market capitalisation is $0.00T as on July 20, 2026 at 8:45 am IST.

How to invest in Contineum Therapeutics Inc. Class A Stock (CTNM) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for Contineum Therapeutics Inc. Class A on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Contineum Therapeutics Inc. Class A Shares that will get you 0.1054 shares as per Contineum Therapeutics Inc. Class A share price of $14.23 per share as on July 20, 2026 at 8:45 am IST.

What is the minimum amount required to buy Contineum Therapeutics Inc. Class A Stock (CTNM) from India?

Indian investors can start investing in Contineum Therapeutics Inc. Class A (CTNM) shares with as little as ₹96.28 or $1 (as of July 20, 2026 at 10:43 am IST) using the INDmoney app.
For example: If you want to invest $10 or ₹962.80 in Contineum Therapeutics Inc. Class A stock (as per the Rupee-Dollar exchange rate as on July 20, 2026 at 10:43 am IST). Based on Contineum Therapeutics Inc. Class A share’s latest price of $14.23 as on July 20, 2026 at 8:45 am IST, you will get 0.7027 shares of Contineum Therapeutics Inc. Class A. Learn more about fractional shares .